KEGG: bha:BH0952
STRING: 272558.BH0952
BH0952 is a protein encoded by the Bacillus halodurans C-125 genome, classified as a UPF0295 family protein. It is a relatively small protein consisting of 121 amino acids . B. halodurans is a rod-shaped, Gram-positive, motile, and spore-forming bacterium typically found in soil, with notable adaptations to alkaline environments. The organism has been reclassified taxonomically, with the current nomenclature being Alkalihalobacillus halodurans .
The BH0952 protein is part of the 4,066 protein-coding genes identified in the 4.2 Mbp B. halodurans genome . While specific functions of BH0952 have not been fully characterized, its study is relevant to understanding protein function in extremophilic bacteria.
For recombinant expression of BH0952, E. coli-based expression systems have proven effective, particularly when using vectors that incorporate a polyhistidine tag for subsequent purification .
Recommended methodology for expression:
Clone the BH0952 gene into an expression vector containing a His-tag (such as pMCSG7, which includes an N-terminal polyhistidine tag followed by a tobacco etch virus (TEV) protease recognition site)
Transform into an appropriate E. coli strain (BL21(DE3) is commonly used)
Culture in either rich media (LB) or minimal media (M9) as follows:
This approach ensures good protein expression while reducing the formation of inclusion bodies. For expression in the native organism, methylation of the plasmid may be necessary to overcome restriction-modification barriers .
Verification of successful expression requires multiple analytical approaches:
SDS-PAGE Analysis: Prepare samples as follows:
Collect induced cells equivalent to 1 ml at OD600 = 3
Centrifuge and resuspend in 50 μl of 0.1 M Tris/HCl, pH 8.0
Add 50 μl solubilization buffer (6% SDS, 1 M dithiothreitol, 0.06% bromophenol blue, 20% sucrose)
Heat at 90°C for 5 minutes
Cool and dilute with 200 μl 0.1 M Tris buffer
Western Blot: Using anti-His antibodies for tagged protein detection
PCR Verification: For recombinant strains, perform colony PCR using appropriate primers targeting the insert region to verify genetic incorporation
Expected outcome: A band corresponding to approximately 15 kDa (varying slightly depending on the expression construct and tags used).
Immobilized Metal Affinity Chromatography (IMAC) is the recommended method for purifying His-tagged BH0952. The following protocol utilizes HisLink™ Resin for gravity-flow column chromatography :
Materials Required:
HisLink™ Protein Purification Resin
HEPES buffer (pH 7.5)
Imidazole
HisLink™ Binding Buffer
HisLink™ Wash Buffer
HisLink™ Elution Buffer
Chromatography column
Procedure:
Cell Lysis:
Use sonication, French press, or commercial reagents like FastBreak™ Cell Lysis Reagent
Add protease inhibitors (1 mM PMSF) to prevent degradation
Add DNase and RNase (up to 20 μg/ml) to reduce lysate viscosity
If using lysozyme, add >300 mM NaCl to binding and wash buffers
Column Preparation:
Equilibrate resin with five column volumes of binding buffer
Sample Application:
Add cleared lysate to the column at a flow rate not exceeding 1-2 ml/minute per ml of column volume
Do not allow the resin to dry after applying the lysate
Washing:
Wash with 10-20 column volumes of wash buffer, divided into 2-3 aliquots
Elution:
For higher purity, a two-step IMAC purification process can be employed:
Initial IMAC purification
TEV protease treatment to cleave the His-tag
Second IMAC step to remove TEV protease, uncleaved protein, and contaminants
Multiple analytical methods should be used in combination:
SDS-PAGE Analysis:
Compare aliquots from different purification steps on a 4-20% gradient gel
Pure BH0952 should appear as a single dominant band at the expected molecular weight
Quantify band intensity using densitometry for relative purity assessment
Protein Concentration Determination:
Bradford or BCA assay for total protein concentration
Absorbance at 280 nm using the calculated extinction coefficient for BH0952
Size Exclusion Chromatography:
Analytical SEC can reveal the presence of aggregates, oligomers, or contaminants of different sizes
Mass Spectrometry:
MALDI-TOF or ESI-MS to confirm the correct mass and identity of the purified protein
Tryptic digest followed by LC-MS/MS for sequence coverage analysis
Expected yield varies depending on expression conditions but typically ranges from 5-15 mg of purified protein per liter of bacterial culture for small proteins like BH0952.
To maximize stability of purified BH0952:
Short-term storage (1-2 weeks):
Store at 4°C in a buffer containing:
50 mM Tris-HCl or HEPES, pH 7.5-8.0
150 mM NaCl
1-5 mM DTT or 0.5-1 mM TCEP (to prevent oxidation)
Optional: 10% glycerol
Long-term storage:
For crystallization purposes:
Concentrate to ≥5 mg/ml in a minimal buffer (e.g., 10-20 mM HEPES, 50-100 mM NaCl)
Remove reducing agents if they interfere with crystallization screens
Filter through a 0.22 μm filter before setting up crystallization trials
Monitor protein stability using analytical size exclusion chromatography or dynamic light scattering before and after storage to detect aggregation or degradation.
Genetic manipulation of B. halodurans presents several challenges that require specialized approaches:
Restriction-Modification Barriers:
Inefficient Transformation:
Plasmid Stability:
Lack of Competence:
The allelic replacement technique for B. halodurans involves:
A shuttle vector with temperature-sensitive origin of replication (pE194ts)
A chloramphenicol resistance cassette (cat gene)
"Payload" sequences with ~1 kb homology flanks for targeted genomic modifications
An antisense secY sequence regulated by an anhydrotetracycline-inducible promoter for counter-selection
B. halodurans thrives in alkaline environments, which has implications for protein expression and function:
pH Adaptation:
Expression Conditions:
Post-translational Modifications:
B. halodurans may have specific post-translational modification systems not present in E. coli
These modifications may be crucial for proper BH0952 function
Co-factor Requirements:
If BH0952 requires co-factors, these may be more readily available in the native host
When expressing in heterologous systems, supplementation may be necessary
When studying BH0952 function, consider comparing properties of the protein expressed in both native B. halodurans and heterologous hosts to identify environment-dependent characteristics.
Several computational methods can provide insights into BH0952 structure and function:
Homology Modeling:
Use tools like SWISS-MODEL, Phyre2, or AlphaFold2
Identify structural homologs in the PDB using HHpred
Evaluate model quality using MolProbity, ProSA, and QMEAN
Sequence Analysis:
Multiple sequence alignment with UPF0295 family proteins
Conservation analysis to identify functionally important residues
Analysis of surrounding genomic context for functional associations
Structural Feature Prediction:
Secondary structure prediction (PSIPRED, JPred)
Disorder prediction (DISOPRED, IUPred)
Binding site prediction (3DLigandSite, CASTp)
Transmembrane region prediction (TMHMM, Phobius)
Functional Prediction:
Gene Ontology term prediction (DeepGOPlus)
Enzyme classification prediction (ECPred)
Protein-protein interaction prediction (STRING database)
Metabolic pathway analysis (KEGG, BioCyc)
For BH0952, comparative analysis with its homologs in other Bacillus species (especially B. subtilis) may provide functional insights, given that 8.8% of B. halodurans CDSs match sequences found only in B. subtilis and 66.7% are widely conserved .
A multi-pronged experimental strategy is recommended:
Structural Analysis:
Biochemical Characterization:
Enzymatic activity assays based on predicted function
In vitro protein-protein interaction assays (pull-down, SPR, ITC)
Substrate binding studies
Thermal stability analysis (DSF, CD spectroscopy)
Genetic Approaches:
Transcriptomic/Proteomic Analysis:
RNA-Seq of knockout strains vs. wild-type
Differential proteomics
Metabolomic profiling
Localization Studies:
GFP fusion proteins
Immunolocalization
Cell fractionation
When selecting methods, consider the hypotheses derived from computational analyses and start with the most promising approaches to efficiently narrow down the potential functions.
When designing experiments involving BH0952, several strategies can optimize data quality and analysis:
Experimental Design Principles:
Control Experiments:
Include appropriate negative controls (e.g., empty vector, inactive mutants)
Use positive controls from related proteins with known function
Implement biological and technical replicates (minimum n=3)
Sequential Experimentation:
Design experiments in stages, with each stage informed by previous results
For structural studies, use a hierarchical approach (prediction → low-resolution → high-resolution)
Algorithm Application:
Statistical Approach:
The above approaches will help in efficiently designing experiments that generate high-quality data and overcome challenges in analyzing results for BH0952, which may have subtle or complex functional characteristics.
When confronted with contradictory results in BH0952 functional studies, a systematic troubleshooting approach is essential:
Methodological Verification:
Validate protein identity via mass spectrometry
Confirm protein folding using circular dichroism or fluorescence spectroscopy
Assess experimental conditions (pH, temperature, buffer composition) that might affect function
Cross-Validation Approaches:
Apply orthogonal methods to test the same hypothesis
Test function in different expression systems (E. coli vs. B. halodurans)
Use both in vitro and in vivo assays
Investigate Potential Confounding Factors:
Protein tags influence on function
Post-translational modifications
Co-factor dependencies
Interaction partners present in one system but not another
Construct Structure-Function Relationship:
Create site-directed mutants of key residues
Test truncated versions to identify functional domains
Analyze chimeric proteins with related family members
Decision Matrix for Contradictory Results:
| Contradiction Type | Investigation Strategy | Resolution Approach |
|---|---|---|
| Activity present in one buffer but not another | Systematic buffer screen varying pH, salt, additives | Identify optimal conditions for activity |
| Function in native host but not E. coli | Test methylated or codon-optimized constructs | Expression with co-factors or chaperones |
| Computational prediction contradicts experimental data | Evaluate prediction confidence, test alternative models | Refine computational model with experimental constraints |
| Phenotype in knockout differs from in vitro activity | Check for compensatory mechanisms, redundant functions | Construct double/triple knockouts of related genes |
| Structural data doesn't explain functional results | Look for conformational changes, allosteric sites | Solve structure in different conditions or bound states |
Remember that contradictions often lead to the most interesting discoveries about protein function and can reveal unexpected aspects of BH0952 biology.
A comprehensive research program for BH0952 characterization should encompass:
Phase I: Basic Characterization (0-12 months)
Recombinant expression and purification optimization
Preliminary structural analysis (CD spectroscopy, limited proteolysis)
Bioinformatic analysis and initial functional predictions
Generation of knockout strain
Phase II: Functional Investigation (12-24 months)
High-resolution structural analysis (X-ray/NMR)
Systematic biochemical activity assays
Transcriptomic/proteomic comparison of knockout vs. wild-type
Phenotypic characterization under various growth conditions
Phase III: Biological Context (24-36 months)
Protein-protein interaction network mapping
Metabolic impact analysis
In vivo localization and dynamics
Evolutionary analysis across related species
Phase IV: Integration and Application (36+ months)
Systems biology modeling of BH0952 role
Engineering applications based on discovered functions
Comparative analysis with homologs from other extremophiles
Sample Research Timeline:
| Timeframe | Key Questions | Methodologies | Expected Outcomes |
|---|---|---|---|
| 0-6 months | Can we obtain pure, active BH0952? | Optimization of expression/purification protocols | Standardized production protocol |
| 6-12 months | What is BH0952's structure? What happens when BH0952 is absent? | Structure determination; knockout generation | Initial structure; viable knockout strain |
| 12-18 months | What molecules does BH0952 interact with? | Binding assays; co-IP; metabolite screening | Identification of binding partners |
| 18-24 months | How does BH0952 respond to environmental changes? | Expression analysis under varied conditions | Regulatory understanding |
| 24-30 months | What is the minimal functional unit of BH0952? | Domain analysis; fragment activity testing | Functional domain map |
| 30-36 months | How is BH0952 integrated into cellular pathways? | Systems biology approaches; network analysis | Pathway models |
This structured approach ensures comprehensive characterization while building on preceding discoveries to guide subsequent experimental directions.